Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 June 2005 : Original article  

Plasma transforming growth factor-b1 in acute viral hepatitis

Robert Flisiak, Danuta Prokopowicz, Jerzy Jaroszewicz, Iwona Flisiak

Med Sci Monit 2005; 11(6): CR304-308 :: ID: 16510

Abstract

Summary
Background: TGFΒ[sub]1[/sub] has a confi rmed role in liver fi brosis and its antiproliferative, proapoptotic, and immunosuppressive
activities can play important roles in the pathogenesis of viral hepatitis.
Material/Methods: The concentrations of transforming growth factor-Β[sub]1[/sub] (TGFΒ[sub]1[/sub]) was measured with enzyme immunoassay in the plasma of 70 patients with acute viral hepatitis types A, B, and C to evaluate an association with the course and severity of the disease.
Results: The highest concentrations of TGFΒ[sub]1[/sub] were observed in the fi rst week of acute viral hepatitis types A and B (52.8±7.4 and 50.0±7.7, respectively). They were signifi cantly higher than normal values or levels in patients with hepatitis type C. Signifi cant correlation was observed between TGFΒ[sub]1[/sub] concentrations and alanine aminotransferase in all groups, whereas with aspartate aminotransferase only hepatitis A and B. A four-week follow-up showed a gradual decrease in TGFΒ[sub]1[/sub] levels in hepatitis A and B patients. In patients with acute C hepatitis, the relatively low initial TGFΒ[sub]1[/sub] concentrations increased in the second and third weeks of follow-up. Among HBV-infected patients the highest TGFΒ[sub]1[/sub] concentrations (75±17 ng/ml) were observed in the severe form of the disease.
Conclusions: These results support an important role of TGF-Β[sub]1[/sub] in the pathogenesis of acute viral hepatitis that seems to be connected with the degree of hepatocyte damage, but not with its mechanism or etiology.

Keywords: Hepatitis C - blood, Hepatitis, Viral, Human - blood, Biological Markers - blood, Hepatitis A - blood, Hepatitis B - blood, Hepatitis C - blood, Hepatitis, Viral, Human - blood, Hepatocytes - pathology, Reference Values, Transforming Growth Factor beta - metabolism, Transforming Growth Factor beta1

Add Comment 0 Comments

Editorial

01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600

0:00

In Press

06 Mar 2024 : Clinical Research  

Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943884  

0:00

08 Mar 2024 : Clinical Research  

Evaluation of Foot Structure in Preschool Children Based on Body Mass

Med Sci Monit In Press; DOI: 10.12659/MSM.943765  

0:00

15 Apr 2024 : Laboratory Research  

The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in Osteoarthritis

Med Sci Monit In Press; DOI: 10.12659/MSM.943738  

0:00

07 Mar 2024 : Clinical Research  

Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...

Med Sci Monit In Press; DOI: 10.12659/MSM.943468  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750